HK inno.N Corporation

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: CJ-12420 200mg
Drug: CJ-12420 200mg + Clarithromycin 500mg
Drug: Clarithromycin 500mg

First Posted Date: 2014-02-03

Last Posted Date: 2016-12-15

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 24

Registration Number: NCT02052336

Locations: 🇰🇷
Inje university college of medicine Busan Paik Hospital, Busan, Korea, Republic of

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

Phase 2

Completed

Conditions: GERD
Erosive Esophagitis

Interventions: Drug: CJ-12420
Drug: Esomeprazole

First Posted Date: 2014-01-07

Last Posted Date: 2014-08-08

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 206

Registration Number: NCT02028663

Locations: 🇰🇷
Seoul National University Hospital and 11 others, Seoul, Korea, Republic of

to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: CJ Imatinib mesylate tablet
Drug: Gleevec film-coated tablet 2 x 100mg

First Posted Date: 2013-08-21

Last Posted Date: 2013-08-21

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 28

Registration Number: NCT01926548

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: CJ-30044
Drug: TALION TAB. 10mg

First Posted Date: 2013-08-19

Last Posted Date: 2013-08-19

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 30

Registration Number: NCT01925313

Locations: 🇰🇷
Yonsei university severance hospital, Seoul, Korea, Republic of

Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin

Phase 1

Withdrawn

Conditions: Healthy

Interventions: Drug: Crestor 20mg(Rosuvastatin calcium 20.80mg) 1Tab
Drug: Concor 5mg(Bisoprolol hemifumarate 5mg) 2Tab
Drug: Concor 5mg 2T and Crestor 20 mg 1Tab

First Posted Date: 2013-08-19

Last Posted Date: 2016-12-29

Lead Sponsor: HK inno.N Corporation

Registration Number: NCT01925300

Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate

Phase 1

Conditions: Healthy

Interventions: Drug: candesartan cilexetil 32mg, amlodipine 10mg

First Posted Date: 2013-05-03

Last Posted Date: 2013-05-03

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 40

Registration Number: NCT01845272

Food-Effect on PK and PD of Single Oral Dose of CJ-12420 in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: CJ-12420 200mg

First Posted Date: 2013-04-12

Last Posted Date: 2013-04-12

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 24

Registration Number: NCT01830309

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

First Posted Date: 2013-01-10

Last Posted Date: 2013-04-09

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 80

Registration Number: NCT01765023

Locations: 🇰🇷
Inje University Pusan Paik Hospital, Busan, Korea, Republic of

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Closone
Drug: Plavix with Astrix

First Posted Date: 2013-01-10

Last Posted Date: 2014-05-12

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 285

Registration Number: NCT01765452

Locations: 🇰🇷
Kosin university gospel hospital, Busan, Korea, Republic of
🇰🇷
Chungbuk national university hospital, Chungbuk, Korea, Republic of
🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

and more 4 locations

Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: CJ Amlodipine/Valsartan 10/160mg Novartis Exforge 10/160mg

First Posted Date: 2012-11-28

Last Posted Date: 2013-09-13

Lead Sponsor: HK inno.N Corporation

Target Recruit Count: 48

Registration Number: NCT01735890

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy